Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Patrick Borgen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

BRCA1 Genes

Chemicals & Drugs

Technetium Tc 99m Sulfur Colloid

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Traina T A; Poggesi I; Robson M; Asnis A; Duncan B A; Heerdt A; Dang C; Lake D; Moasser M; Panageas K; Borgen P; Norton L; Hudis C; Dickler M N
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.
Tan Lee K; Giri Dilip; Hummer Amanda J; Panageas Katherine S; Brogi Edi; Norton Larry; Hudis Clifford; Borgen Patrick I; Cody Hiram S
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.
Yu Jeanne; Park Anna; Morris Elizabeth; Liberman Laura; Borgen Patrick I; King Tari A
MRI screening in a clinic population with a family history of breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patrick Borgen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Traina T A; Poggesi I; Robson M; Asnis A; Duncan B A; Heerdt A; Dang C; Lake D; Moasser M; Panageas K; Borgen P; Norton L; Hudis C; Dickler M N
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.
Breast cancer research and treatment 2008;111(2):377-88.
2008: Tan Lee K; Giri Dilip; Hummer Amanda J; Panageas Katherine S; Brogi Edi; Norton Larry; Hudis Clifford; Borgen Patrick I; Cody Hiram S
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1803-9.
2008: Yu Jeanne; Park Anna; Morris Elizabeth; Liberman Laura; Borgen Patrick I; King Tari A
MRI screening in a clinic population with a family history of breast cancer.
Annals of surgical oncology 2008;15(2):452-61.
2008: Chan Sharon Wing-wai; LaVigne Katherine A; Port Elisa R; Fey Jane V; Brogi Edi; Borgen Patrick I; Cody Hiram S
Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?
Annals of surgery 2008;247(1):143-9.
2008: Olshen Adam B; Gold Bert; Lohmueller Kirk E; Struewing Jeffery P; Satagopan Jaya; Stefanov Stefan A; Eskin Eleazar; Kirchhoff Tomas; Lautenberger James A; Klein Robert J; Friedman Eitan; Norton Larry; Ellis Nathan A; Viale Agnes; Lee Catherine S; Borgen Patrick I; Clark Andrew G; Offit Kenneth; Boyd Jeff
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.
BMC genetics 2008;9():14.
2007: Morrogh Mary; Morris Elizabeth A; Liberman Laura; Borgen Patrick I; King Tari A
The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge.
Annals of surgical oncology 2007;14(12):3369-77.
2007: Morrogh Mary; Borgen Patrick I; King Tari A
The importance of local control in early-stage breast cancer: a historical review and a discussion of ongoing issues.
Annals of surgical oncology 2007;14(12):3310-20.
2007: King Tari A; Li Weiwei; Brogi Edi; Yee Cindy J; Gemignani Mary L; Olvera Narciso; Levine Douglas A; Norton Larry; Robson Mark E; Offit Kenneth; Borgen Patrick I; Boyd Jeff
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
Annals of surgical oncology 2007;14(9):2510-8.
2007: Beal Kathryn; McCormick Beryl; Zelefsky Michael J; Borgen Patrick; Fey Jane; Goldberg Jessica; Cohen Gilad N; Sacchini Virgilio
Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results.
International journal of radiation oncology, biology, physics 2007;69(1):19-24.
2007: Bevilacqua José Luiz B; Kattan Michael W; Fey Jane V; Cody Hiram S; Borgen Patrick I; Van Zee Kimberly J
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3670-9.
2007: Port Elisa Rush; Garcia-Etienne Carlos A; Park Julia; Fey Jane; Borgen Patrick I; Cody Hiram S
Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.
Annals of surgical oncology 2007;14(8):2209-14.
2007: Morrogh Mary; Olvera Narciso; Bogomolniy Faina; Borgen Patrick I; King Tari A
Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue.
BioTechniques 2007;43(1):41-2, 44, 46 passim.
2007: Baron Roberta H; Fey Jane V; Borgen Patrick I; Stempel Michelle M; Hardick Kathleen R; Van Zee Kimberly J
Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Annals of surgical oncology 2007;14(5):1653-61.
2007: Wright Mary Jo; Park Julia; Fey Jane V; Park Anna; O'Neill Anne; Tan Lee K; Borgen Patrick I; Cody Hiram S; Van Zee Kimberly J; King Tari A
Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter?
Journal of the American College of Surgeons 2007;204(4):541-9.
2007: Park Julia; Fey Jane V; Naik Arpana M; Borgen Patrick I; Van Zee Kimberly J; Cody Hiram S
A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.
Annals of surgery 2007;245(3):462-8.
2007: Port Elisa Rush; Park Anna; Borgen Patrick I; Morris Elizabeth; Montgomery Leslie L
Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Annals of surgical oncology 2007;14(3):1051-7.
2007: Sukumvanich P; Bentrem D J; Cody H S; Brogi E; Fey J V; Borgen P I; Gemignani M L
The role of sentinel lymph node biopsy in Paget's disease of the breast.
Annals of surgical oncology 2007;14(3):1020-3.
2006: Sacchini Virgilio; Pinotti José A; Barros Alfredo C S D; Luini Alberto; Pluchinotta Alfonso; Pinotti Marianne; Boratto Marcelo G; Ricci Marco D; Ruiz Carlos A; Nisida Antonio C; Veronesi Paolo; Petit Jean; Arnone Paolo; Bassi Fabio; Disa Joseph J; Garcia-Etienne Carlos A; Borgen Patrick I
Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
Journal of the American College of Surgeons 2006;203(5):704-14.
2006: Goldberg Jessica I; Borgen Patrick I
Breast cancer susceptibility testing: past, present and future.
Expert review of anticancer therapy 2006;6(8):1205-14.
2006: Garcia-Etienne Carlos A; Borgen Patrick I
Update on the indications for nipple-sparing mastectomy.
The journal of supportive oncology 2006;4(5):225-30.
2006: Bevers Therese B; Anderson Benjamin O; Bonaccio Ermelinda; Borgen Patrick I; Buys Saundra; Daly Mary B; Dempsey Peter J; Farrar William B; Fleming Irving; Garber Judy E; Harris Randall E; Helvie Mark; Hoover Susan; Krontiras Helen; Shaw Sara; Singletary Eva; Sugg Skinner Celette; Smith Mary Lou; Tsangaris Theodore N; Wiley Elizabeth L; Williams Cheryl;
Breast cancer screening and diagnosis.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(5):480-508.
2006: Port Elisa Rush; Yeung Henry; Gonen Mithat; Liberman Laura; Caravelli James; Borgen Patrick; Larson Steven
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Annals of surgical oncology 2006;13(5):677-84.
2005: Buchanan Claire L; Morris Elizabeth A; Dorn Paige L; Borgen Patrick I; Van Zee Kimberly J
Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Annals of surgical oncology 2005;12(12):1045-53.
2005: Kauff Noah D; Mitra Nandita; Robson Mark E; Hurley Karen E; Chuai Shaokun; Goldfrank Deborah; Wadsworth Eve; Lee Johanna; Cigler Tessa; Borgen Patrick I; Norton Larry; Barakat Richard R; Offit Kenneth
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Journal of the National Cancer Institute 2005;97(18):1382-4.
2005: Levine Douglas A; Bogomolniy Faina; Yee Cindy J; Lash Alex; Barakat Richard R; Borgen Patrick I; Boyd Jeff
Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2875-8.
2005: Mendez Jane E; Fey Jane V; Cody Hiram; Borgen Patrick I; Sclafani Lisa M
Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
Annals of surgical oncology 2005;12(1):24-8.
2005: Kim S-W; Lee C S; Fey J V; Borgen P I; Boyd J
Prevalence of BRCA2 mutations in a hospital based series of unselected breast cancer cases.
Journal of medical genetics 2005;42(1):e5.
2005: Specht Michelle C; Fey Jane V; Borgen Patrick I; Cody Hiram S
Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Journal of the American College of Surgeons 2005;200(1):10-4.
2005: Robson Mark; Svahn Tiffany; McCormick Beryl; Borgen Patrick; Hudis Clifford A; Norton Larry; Offit Kenneth
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
Cancer 2005;103(1):44-51.
2004: Kattan Michael W; Giri Dilip; Panageas Katherine S; Hummer Amanda; Cranor Milicent; Van Zee Kimberly J; Hudis Clifford A; Norton Larry; Borgen Patrick I; Tan Lee K
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Cancer 2004;101(11):2509-15.
2004: Specht Michelle C; Borgen Patrick I; Fey Jane; Zhang Zi; Sclafani Lisa
Personal health behaviors in women who have undergone risk-reducing mastectomy.
American journal of surgery 2004;188(4):448-9.
2004: Sacchini Virgilio; Borgen Patrick I
Can radiation therapy for breast cancer be avoided?
Lancet 2004;364(9438):916-7.
2004: King Tari A; Ganaraj Archana; Fey Jane V; Tan Lee K; Hudis Clifford; Norton Larry; Cody Hiram S; Borgen Patrick I
Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
Cancer 2004;101(5):926-33.
2004: Naik Arpana M; Fey Jane; Gemignani Mary; Heerdt Alexandra; Montgomery Leslie; Petrek Jeanne; Port Elisa; Sacchini Virgilio; Sclafani Lisa; VanZee Kimberly; Wagman Raquel; Borgen Patrick I; Cody Hiram S
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.
Annals of surgery 2004;240(3):462-8; discussion 468-71.
2004: King Tari A; Gemignani Mary L; Li Weiwei; Giri Dilip D; Panageas Kathy S; Bogomolniy Faina; Arroyo Crispinita; Olvera Narciso; Robson Mark E; Offit Kenneth; Borgen Patrick I; Boyd Jeff
Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
Cancer research 2004;64(15):5051-3.
2004: Baron Roberta H; Fey Jane V; Borgen Patrick I; Van Zee Kimberly J
Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Oncology nursing forum 2004;31(4):691-8.
2004: King Tari A; Fey Jane V; Van Zee Kimberly J; Heerdt Alexandra S; Gemignani Mary L; Port Elisa Rush; Sclafani Lisa; Sacchini Virgilio; Petrek Jeanne A; Cody Hiram S; Borgen Patrick I; Montgomery Leslie L
A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.
Annals of surgical oncology 2004;11(5):535-41.
2004: Cody Hiram S; Borgen Patrick I; Tan Lee K
Redefining prognosis in node-negative breast cancer: can sentinel lymph node biopsy raise the threshold for systemic adjuvant therapy?
Annals of surgical oncology 2004;11(3 Suppl):227S-30S.
2004: Moore Katrina H; Thaler Howard T; Tan Lee K; Borgen Patrick I; Cody Hiram S
Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: biologic metastasis or procedural artifact?
Cancer 2004;100(5):929-34.
2004: Quan May Lynn; Fey Jane; Eitan Ram; Abu-Rustum Nadeem R; Barakat Richard R; Borgen Patrick I; Gemignani Mary L
Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer.
Gynecologic oncology 2004;92(1):327-30.
2003: Van Zee Kimberly J; Manasseh Donna-Marie E; Bevilacqua Jose L B; Boolbol Susan K; Fey Jane V; Tan Lee K; Borgen Patrick I; Cody Hiram S; Kattan Michael W
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Annals of surgical oncology 2003;10(10):1140-51.
2003: Derossis Anna M; Fey Jane V; Cody Hiram S; Borgen Patrick I
Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.
Journal of the American College of Surgeons 2003;197(6):896-901.
2003: Quan M L; Sclafani L; Heerdt A S; Fey J V; Morris E A; Borgen P I
Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer.
Annals of surgical oncology 2003;10(9):1048-53.
2003: Tousimis Eleni; Van Zee Kimberly J; Fey Jane V; Hoque Laura Weldon; Tan Lee K; Cody Hiram S; Borgen Patrick I; Montgomery Leslie L
The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers.
Journal of the American College of Surgeons 2003;197(4):529-35.
2003: Singletary S Eva; Allred Craig; Ashley Pandora; Bassett Lawrence W; Berry Donald; Bland Kirby I; Borgen Patrick I; Clark Gary M; Edge Stephen B; Hayes Daniel F; Hughes Lorie L; Hutter Robert V P; Morrow Monica; Page David L; Recht Abram; Theriault Richard L; Thor Ann; Weaver Donald L; Wieand H Samuel; Greene Frederick L
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.
The Surgical clinics of North America 2003;83(4):803-19.
2003: Hurria Arti; Leung Denis; Trainor Kathleen; Borgen Patrick; Norton Larry; Hudis Clifford
Factors influencing treatment patterns of breast cancer patients age 75 and older.
Critical reviews in oncology/hematology 2003;46(2):121-6.
2003: Kauff Noah D; Brogi Edi; Scheuer Lauren; Pathak Dorothy R; Borgen Patrick I; Hudis Clifford A; Offit Kenneth; Robson Mark E
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
Cancer 2003;97(7):1601-8.
2002: Bevilacqua J L B; Gucciardo G; Cody H S; MacDonald K A; Sacchini V; Borgen P I; Van Zee K J
A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2002;28(6):603-14.
2002: Singletary S Eva; Allred Craig; Ashley Pandora; Bassett Lawrence W; Berry Donald; Bland Kirby I; Borgen Patrick I; Clark Gary; Edge Stephen B; Hayes Daniel F; Hughes Lorie L; Hutter Robert V P; Morrow Monica; Page David L; Recht Abram; Theriault Richard L; Thor Ann; Weaver Donald L; Wieand H Samuel; Greene Frederick L
Revision of the American Joint Committee on Cancer staging system for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3628-36.
2002: Bevilacqua J; Cody H; MacDonald K A; Tan L K; Borgen P I; Van Zee K J
A prospective validated model for predicting axillary node metastases based on 2,000 sentinel node procedures: the role of tumour location [corrected].
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2002;28(5):490-500.
2002: Port Elisa Rush; Fey Jane; Gemignani Mary L; Heerdt Alexandra S; Montgomery Leslie L; Petrek Jeanne A; Sacchini Virgilio; Van Zee Kimberly J; Borgen Patrick I; Cody Hiram S
Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma.
Journal of the American College of Surgeons 2002;195(2):167-72.
2002: Temple Larissa K F; Baron Roberta; Cody Hiram S; Fey Jane V; Thaler Howard T; Borgen Patrick I; Heerdt Alexander S; Montgomery Leslie L; Petrek Jeanne A; Van Zee Kimberly J
Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women.
Annals of surgical oncology 2002;9(7):654-62.
2002: Montgomery Leslie L; Thorne Alisa C; Van Zee Kimberly J; Fey Jane; Heerdt Alexandra S; Gemignani Mary; Port Elisa; Petrek Jeanne; Cody Hiram S; Borgen Patrick I
Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer.
Anesthesia and analgesia 2002;95(2):385-8, table of contents.
2002: Kauff Noah D; Satagopan Jaya M; Robson Mark E; Scheuer Lauren; Hensley Martee; Hudis Clifford A; Ellis Nathan A; Boyd Jeff; Borgen Patrick I; Barakat Richard R; Norton Larry; Castiel Mercedes; Nafa Khedoudja; Offit Kenneth
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
The New England journal of medicine 2002;346(21):1609-15.
2002: Baron Roberta H; Fey Jane V; Raboy Sara; Thaler Howard T; Borgen Patrick I; Temple Larissa K F; Van Zee Kimberly J
Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Oncology nursing forum 2002;29(4):651-9.
2002: Scheuer Lauren; Kauff Noah; Robson Mark; Kelly Bridget; Barakat Richard; Satagopan Jaya; Ellis Nathan; Hensley Martee; Boyd Jeff; Borgen Patrick; Norton Larry; Offit Kenneth
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1260-8.
2002: Klauber-Demore Nancy; Boolbol Susan K; Derossis Anna M; Ruo Leyo; Bernik Stephanie F; Borgen Patrick I
Randomized clinical trials in breast cancer.
Surgical oncology clinics of North America 2002;11(1):53-88, viii.
2001: Sacchini G; Borgen P I; Galimberti V; Veronesi P; Zurrida S; Luini A; Spaggiari L; Cody H S; Veronesi U
Surgical approach to internal mammary lymph node biopsy.
Journal of the American College of Surgeons 2001;193(6):709-13.
2001: Kauff N D; Scheuer L; Robson M E; Glogowski E; Kelly B; Barakat R; Heerdt A; Borgen P I; Davis J G; Offit K
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.
Genetics in medicine : official journal of the American College of Medical Genetics 2001;3(6):422-5.
2001: Klauber-DeMore N; Bevilacqua J L; Van Zee K J; Borgen P; Cody H S
Comprehensive review of the management of internal mammary lymph node metastases in breast cancer.
Journal of the American College of Surgeons 2001;193(5):547-55.
2001: Derossis A M; Fey J; Yeung H; Yeh S D; Heerdt A S; Petrek J; VanZee K J; Montgomery L L; Borgen P I; Cody H S
A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.
Journal of the American College of Surgeons 2001;193(5):473-8.
2001: McCarter M D; Yeung H; Yeh S; Fey J; Borgen P I; Cody H S
Localization of the sentinel node in breast cancer: identical results with same-day and day-before isotope injection.
Annals of surgical oncology 2001;8(8):682-6.
2001: Cody H S; Klauber-Demore N; Borgen P I; Van Zee K J
Is it really duct carcinoma in situ?
Annals of surgical oncology 2001;8(8):617-9.
2001: Martin R C; Derossis A M; Fey J; Yeung H; Yeh S D; Akhurst T; Heerdt A S; Petrek J; VanZee K J; Montgomery L L; Borgen P I; Cody H S
Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.
Surgery 2001;130(3):432-8.
2001: Boolbol S K; Borgen P I
Sentinel lymph node biopsy: an American perspective.
Breast (Edinburgh, Scotland) 2001;10(4):287-90.
2001: Martin R C; Fey J; Yeung H; Borgen P I; Cody H S
Highest isotope count does not predict sentinel node positivity in all breast cancer patients.
Annals of surgical oncology 2001;8(7):592-7.
2001: Port E R; Montgomery L L; Heerdt A S; Borgen P I
Patient reluctance toward tamoxifen use for breast cancer primary prevention.
Annals of surgical oncology 2001;8(7):580-5.
2001: Klauber-DeMore N; Van Zee K J; Linkov I; Borgen P I; Gerald W L
Biological behavior of human breast cancer micrometastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2434-9.
2001: McCarter M D; Yeung H; Fey J; Borgen P I; Cody H S
The breast cancer patient with multiple sentinel nodes: when to stop?
Journal of the American College of Surgeons 2001;192(6):692-7.
2001: Robson M E; Boyd J; Borgen P I; Cody H S
Hereditary breast cancer.
Current problems in surgery 2001;38(6):387-480.
2001: Van Poznak C; Seidman A D; Reidenberg M M; Moasser M M; Sklarin N; Van Zee K; Borgen P; Gollub M; Bacotti D; Yao T J; Bloch R; Ligueros M; Sonenberg M; Norton L; Hudis C
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.
Breast cancer research and treatment 2001;66(3):239-48.
2001: Bisogna M; Calvano J E; Ho G H; Orlow I; Cordón-Cardó C; Borgen P I; Van Zee K J
Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
Cancer genetics and cytogenetics 2001;125(2):131-8.
2001: Weiser M R; Montgomery L L; Tan L K; Susnik B; Leung D Y; Borgen P I; Cody H S
Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes.
Annals of surgical oncology 2001;8(2):145-9.
2001: Ho G H; Calvano J E; Bisogna M; Abouezzi Z; Borgen P I; Cordón-Cardó C; van Zee K J
Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.
Breast cancer research and treatment 2001;65(3):225-32.
2001: Boolbol S K; Fey J V; Borgen P I; Heerdt A S; Montgomery L L; Paglia M; Petrek J A; Cody H S; Van Zee K J
Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
Annals of surgical oncology 2001;8(1):20-4.
2001: Cody H S; Fey J; Akhurst T; Fazzari M; Mazumdar M; Yeung H; Yeh S D; Borgen P I
Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.
Annals of surgical oncology 2001;8(1):13-9.
2001: Port E R; Fey J V; Cody H S; Borgen P I
Sentinel lymph node biopsy in patients with male breast carcinoma.
Cancer 2001;91(2):319-23.
2000: Ho G H; Calvano J E; Bisogna M; Borgen P I; Rosen P P; Tan L K; Van Zee K J
In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology.
Cancer 2000;89(11):2153-60.
2000: Olson J A; Fey J; Winawer J; Borgen P I; Cody H S; Van Zee K J; Petrek J; Heerdt A S
Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Journal of the American College of Surgeons 2000;191(6):593-9.
2000: Weiser M R; Montgomery L L; Susnik B; Tan L K; Borgen P I; Cody H S
Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?
Annals of surgical oncology 2000;7(9):651-5.
2000: Klauber-DeMore N; Tan L K; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek J A; Cody H S; Van Zee K J
Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
Annals of surgical oncology 2000;7(9):636-42.
2000: Baron R H; Kelvin J F; Bookbinder M; Cramer L; Borgen P I; Thaler H T
Patients' sensations after breast cancer surgery. A pilot study.
Cancer practice 2000;8(5):215-22.
2000: Gemignani M L; Cody H S; Fey J V; Tran K N; Venkatraman E; Borgen P I
Impact of sentinel lymph node mapping on relative charges in patients with early-stage breast cancer.
Annals of surgical oncology 2000;7(8):575-80.
2000: Olson J A; Morris E A; Van Zee K J; Linehan D C; Borgen P I
Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
Annals of surgical oncology 2000;7(6):411-5.
2000: Payne D K; Biggs C; Tran K N; Borgen P I; Massie M J
Women's regrets after bilateral prophylactic mastectomy.
Annals of surgical oncology 2000;7(2):150-4.
1999: Robson M; Levin D; Federici M; Satagopan J; Bogolminy F; Heerdt A; Borgen P; McCormick B; Hudis C; Norton L; Boyd J; Offit K
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
Journal of the National Cancer Institute 1999;91(24):2112-7.
1999: Van Zee K J; Liberman L; Samli B; Tran K N; McCormick B; Petrek J A; Rosen P P; Borgen P I
Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
Cancer 1999;86(9):1757-67.
1999: Gemignani M L; Petrek J A; Borgen P I
Breast cancer and pregnancy.
The Surgical clinics of North America 1999;79(5):1157-69.
1999: Mann G B; Port E R; Rizza C; Tan L K; Borgen P I; Van Zee K J
Six-year follow-up of patients with microinvasive, T1a, and T1b breast carcinoma.
Annals of surgical oncology 1999;6(6):591-8.
1999: Montgomery L L; Tran K N; Heelan M C; Van Zee K J; Massie M J; Payne D K; Borgen P I
Issues of regret in women with contralateral prophylactic mastectomies.
Annals of surgical oncology 1999;6(6):546-52.
1999: Heerdt A S; Borgen P I
Current status of tamoxifen use: An update for the surgical oncologist.
Journal of surgical oncology 1999;72(1):42-9.
1999: Hill A; Yagmur Y; Tran K N; Bolton J S; Robson M; Borgen P I
Localized male breast carcinoma and family history. An analysis of 142 patients.
Cancer 1999;86(5):821-5.
1999: Cody H S; Borgen P I
State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center.
Surgical oncology 1999;8(2):85-91.
1999: Hill A D; Borgen P I; Cody H S
Sentinel node biopsy in male breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999;25(4):442-3.
1999: Linehan D C; Hill A D; Akhurst T; Yeung H; Yeh S D; Tran K N; Borgen P I; Cody H S
Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.
Annals of surgical oncology 1999;6(5):450-4.
1999: Liberman L; Cody H S; Hill A D; Rosen P P; Yeh S D; Akhurst T; Morris E A; Abramson A F; Borgen P I; Dershaw D D
Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer.
Radiology 1999;211(3):835-44.
1999: Hill A D; Mann G B; Borgen P I; Cody H S
Sentinel lymphatic mapping in breast cancer.
Journal of the American College of Surgeons 1999;188(5):545-9.
1999: Cody H S; Hill A D; Tran K N; Brennan M F; Borgen P I
Credentialing for breast lymphatic mapping: how many cases are enough?
Annals of surgery 1999;229(5):723-6; discussion 726-8.
1999: Hill A D; Tran K N; Akhurst T; Yeung H; Yeh S D; Rosen P P; Borgen P I; Cody H S
Lessons learned from 500 cases of lymphatic mapping for breast cancer.
Annals of surgery 1999;229(4):528-35.
1999: Linehan D C; Hill A D; Tran K N; Yeung H; Yeh S D; Borgen P I; Cody H S
Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered.
Journal of the American College of Surgeons 1999;188(4):377-81.
1999: Boyd J; Rhei E; Federici M G; Borgen P I; Watson P; Franklin B; Karr B; Lynch J; Lemon S J; Lynch H T
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.
Breast cancer research and treatment 1999;53(1):87-91.
1998: Hwang E S; Samli B; Tran K N; Rosen P P; Borgen P I; Van Zee K J
Volume of resection in patients treated with breast conservation for ductal carcinoma in situ.
Annals of surgical oncology 1998;5(8):757-63.
1998: Borgen P I; Hill A D; Tran K N; Van Zee K J; Massie M J; Payne D; Biggs C G
Patient regrets after bilateral prophylactic mastectomy.
Annals of surgical oncology 1998;5(7):603-6.
1998: Kim S H; Simkovich-Heerdt A; Tran K N; Maclean B; Borgen P I
Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy.
Journal of the American College of Surgeons 1998;187(1):1-8.
1998: Robson M; Gilewski T; Haas B; Levin D; Borgen P; Rajan P; Hirschaut Y; Pressman P; Rosen P P; Lesser M L; Norton L; Offit K
BRCA-associated breast cancer in young women.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1642-9.
1998: Mann G B; Borgen P I
Breast cancer genes and the surgeon.
Journal of surgical oncology 1998;67(4):267-74.
1998: O'Hea B J; Hill A D; El-Shirbiny A M; Yeh S D; Rosen P P; Coit D G; Borgen P I; Cody H S
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.
Journal of the American College of Surgeons 1998;186(4):423-7.
1998: Liberman L; Dershaw D D; Rosen P P; Morris E A; Abramson A F; Borgen P I
Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy.
Radiology 1998;206(3):711-5.
1998: Port E R; Tan L K; Borgen P I; Van Zee K J
Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma.
Annals of surgical oncology 1998;5(1):23-7.
1997: Hudis C A; Borgen P
Systemic treatment for stage I and stage II breast cancer.
Surgical oncology clinics of North America 1997;6(4):683-98.
1997: Rhei E; Kang L; Bogomolniy F; Federici M G; Borgen P I; Boyd J
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Cancer research 1997;57(17):3657-9.
1997: Calvano J E; Rush E B; Tan L K; Rosen P P; Borgen P I; Van Zee K J
Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.
Annals of surgical oncology 1997;4(5):416-20.
1997: Borgen P I; Senie R T; McKinnon W M; Rosen P P
Carcinoma of the male breast: analysis of prognosis compared with matched female patients.
Annals of surgical oncology 1997;4(5):385-8.
1997: Rush E B; Calvano J E; van Zee K J; Zelenetz A D; Borgen P I
Microsatellite instability in breast cancer.
Annals of surgical oncology 1997;4(4):310-5.
1997: Baron R H; Borgen P I
Genetic susceptibility for breast cancer: testing and primary prevention options.
Oncology nursing forum 1997;24(3):461-8.
1997: Dershaw D D; Giess C S; McCormick B; Borgen P; Liberman L; Abramson A F; Morris E
Patterns of mammographically detected calcifications after breast-conserving therapy associated with tumor recurrence.
Cancer 1997;79(7):1355-61.
1997: Liberman L; LaTrenta L R; Dershaw D D; Abramson A F; Morris E A; Cohen M A; Rosen P P; Borgen P I
Impact of core biopsy on the surgical management of impalpable breast cancer.
AJR. American journal of roentgenology 1997;168(2):495-9.
1996: Oddoux C; Struewing J P; Clayton C M; Neuhausen S; Brody L C; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
Nature genetics 1996;14(2):188-90.
1996: Swallow C J; Van Zee K J; Sacchini V; Borgen P I
Ductal carcinoma in situ of the breast: progress and controversy.
Current problems in surgery 1996;33(7):553-600.
1996: Neuhausen S; Gilewski T; Norton L; Tran T; McGuire P; Swensen J; Hampel H; Borgen P; Brown K; Skolnick M; Shattuck-Eidens D; Jhanwar S; Goldgar D; Offit K
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
Nature genetics 1996;13(1):126-8.
1996: Anderson B O; Petrek J A; Byrd D R; Senie R T; Borgen P I
Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger.
Annals of surgical oncology 1996;3(2):204-11.
1995: Youngson B J; Anelli A; Van Zee K J; Borgen P I; Norton L; Rosen P P
Microdissection and molecular genetic analysis of HER2/neu in breast carcinoma.
The American journal of surgical pathology 1995;19(12):1354-8.
1995: Anderson B O; Senie R T; Vetto J T; Wong G Y; McCormick B; Borgen P I
Improved survival in young women with breast cancer.
Annals of surgical oncology 1995;2(5):407-15.
1995: Anelli A; Anelli T F; Youngson B; Rosen P P; Borgen P I
Mutations of the p53 gene in male breast cancer.
Cancer 1995;75(9):2233-8.
1995: Rosen P P; Lesser M L; Arroyo C D; Cranor M; Borgen P; Norton L
p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):821-30.
1995: Rush E B; Abouezzi Z; Borgen P I; Anelli A
Analysis of MTS1/CDK4 in female breast carcinomas.
Cancer letters 1995;89(2):223-6.
1995: Borgen P I; Heerdt A S; Moore M P; Petrek J A
Breast conservation therapy for invasive carcinoma of the breast.
Current problems in surgery 1995;32(3):191-248.
1995: Rosen P P; Lesser M L; Arroyo C D; Cranor M; Borgen P; Norton L
Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.
Cancer 1995;75(6):1320-6.
1995: Heerdt A S; Young C W; Borgen P I
Calcium glucarate as a chemopreventive agent in breast cancer.
Israel journal of medical sciences 1995;31(2-3):101-5.
1994: Lebwohl D E; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Oncogene 1994;9(7):1925-9.
1994: Anelli T F; Anelli A; Tran K N; Lebwohl D E; Borgen P I
Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.
Cancer 1994;74(1):74-7.
1993: Dershaw D D; Borgen P I; Deutch B M; Liberman L
Mammographic findings in men with breast cancer.
AJR. American journal of roentgenology 1993;160(2):267-70.
1992: Williard W; Borgen P; Bol R; Tiwari R; Osborne M
Cowden's disease. A case report with analyses at the molecular level.
Cancer 1992;69(12):2969-74.
1992: Borgen P I; Wong G Y; Vlamis V; Potter C; Hoffmann B; Kinne D W; Osborne M P; McKinnon W M
Current management of male breast cancer. A review of 104 cases.
Annals of surgery 1992;215(5):451-7; discussion 457-9.
1992: Osborne M P; Borgen P I; Wong G Y; Rosen P P; McCormick B
Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.
Surgery, gynecology & obstetrics 1992;174(3):189-94.
1991: Borgen P I
Male breast cancer.
Seminars in surgical oncology 1991;7(5):314-9.
1991: Fracchia A A; Borgen P I
Bilateral breast cancer.
Seminars in surgical oncology 1991;7(5):300-5.
1990: Osborne M P; Borgen P I
Role of mastectomy in breast cancer.
The Surgical clinics of North America 1990;70(5):1023-46.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Patrick Borgen

Research Profile (preview)

Disorders

Procedures

Anatomy

Concepts & Ideas

Genes & Molecular Sequences

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Patrick Borgen (preview)

All Publications